HCPCS S9562 — Ht inj palivizumab/ab diem (2026 RVU Values)
HCPCS code S9562 (Ht inj palivizumab/ab diem) is published in the 2026 CMS Physician Fee Schedule. Use this page as a reference for billing, productivity tracking, and compensation modeling.
How Medicare handles HCPCS S9562
Medicare status: Not valid for Medicare. Medicare does not recognize this code for payment. Other payers may still accept it, so it remains useful for coding reference and non-Medicare billing.